Danny Jomaa completed his MSc in Biochemistry at the University of Ottawa under the supervision of Dr. Ian Lorimer. His thesis work used CRISPR/Cas9 to knockout PREX1 in primary glioblastoma cell lines and examine the impact on motility and intercellular communication in vitro. In addition, Danny has experience with using bioinformatics in the context of cancer genetics and newborn screening research.
Danny is currently a second-year medical student at Queen’s University and is interested in bridging his interests in medicine and research in the future. To this end, he is joining the Lochmüller Lab as a summer research student for summer 2020. He will be investigating pediatric patients who have been diagnosed with congenital myasthenic syndromes without a known causative gene. Using sequencing and phenotype data, Danny will work on identifying the genetic variants that are responsible for their diagnoses.
